Anya Biopharm Inc. (TPEX:7776)

Market Cap	1.31B -28.0%
Revenue (ttm)	16.27M -24.7%
Net Income	-64.02M
EPS	-1.30
Shares Out	49.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	66,968
Average Volume	51,346
Open	27.60
Previous Close	27.50
Day's Range	26.65 - 28.00
52-Week Range	24.10 - 70.60
Beta	n/a
RSI	23.47
Earnings Date	Apr 27, 2026

About Anya Biopharm

Anya Biopharm Inc., a pharmaceutical company, develops platforms for the delivery of oral peptides in Taiwan, rest of Asia, and Europe. The company is also developing ANY002 and ANY004, oral GLP1 products; ANY003, a tnfα inhibitor; and ANY00x. In addition, it engages in the research, development, and testing business. Anya Biopharm Inc. was founded in 2016 and is based in Taipei, Taiwan.

• Industry: Pharmaceutical Preparations
• Founded: 2016
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7776

Financial Performance

In 2025, Anya Biopharm's revenue was 16.27 million, a decrease of -24.66% compared to the previous year's 21.60 million. Losses were -64.02 million, 73.2% more than in 2024.